Posts tagged Matrixxx.
Blogs
2 minute read
On March 22, 2011 the U.S. Supreme Court handed down a decision which is likely to have serious repercussions for companies in the bio/pharma tech space. In MATRIXX INITIATIVES, INC., ET AL. v. SIRACUSANO ET AL., the Court rejected Matrixx argument that reports regarding the adverse effect of Zicam, its leading revenue generating product, were not statistically significant and therefore not material.
Noting that the analysis of materiality under the securities laws in fact specific, the Court appears to have relied heavily on two factors:
1. The methodologies and requirements ...
Blog Editors
Recent Updates
- Watch: 401(k) Alternative Assets, NLRB Removal Protections, and Military Leave Requests - Employment Law This Week
- Watch: Employer AI Headaches - Job Postings, Client Privilege, and Microchip Bans - Employment Law This Week
- Video: Is Cemex Still Valid? Sixth Circuit Creates Uncertainty - Employment Law This Week
- Podcast: Non-Competes in 2026 - FTC Signals Major Policy Shift – Employment Law This Week
- In Lawsuits, Facts Matter. Employers That Embrace DEI Can Weather the Storm